Prurigo Nodularis
📧 Sign up to get email alerts when something new happens for Prurigo Nodularis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases [Phase 1]
BeiGene is conducting a Phase 1 trial to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of single- and multiple-asc…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) [Phase 3]
A Phase 3 clinical trial evaluating povorcitinib for prurigo nodularis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1) [Phase 3]
Phase 3 clinical trial evaluating povorcitinib for efficacy and safety in participants with prurigo nodularis; the study is currently recrui…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis [Phase 2]
Phase 2 clinical trial update for ICP-332 in Prurigo nodularis. The study is currently recruiting to evaluate efficacy and safety.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
This clinical-trial update describes real-world use of nemolizumab in adults with moderate-to-severe prurigo nodularis and indicates recruit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study of Barzolvolimab in Patients With Prurigo Nodularis [Phase 2]
This entry notes a Phase 2 clinical trial of Barzolvolimab for prurigo nodularis and indicates the study is currently not actively recruitin…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis [Phase 3]
An update on Amgen's Phase 3, double-blind, placebo-controlled trial of rocatinlimab for prurigo nodularis, currently active but not recruit…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis [Phase 3]
A Phase 3 study evaluating the pharmacokinetics and safety of dupilumab in children aged 6 months to under 18 years with prurigo nodularis; …
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis
This clinical trial update examines the early and long-term efficacy and immune changes of dupilumab in prurigo nodularis. The study is curr…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life [NA]
Clinical trial update noting the completion of a study evaluating the EMD Protocol for Urge and its effect on dermatology-specific quality o…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
This document reports real-world observational findings on the effectiveness of dupilumab in patients with prurigo nodularis. The study is c…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
An observational, non-interventional study evaluating long-term dupilumab treatment, safety, and patient-reported outcomes in chronic nodula…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Determinants of Chronic Inflammatory Skin Disease Trajectories
An ongoing clinical study is investigating determinants of chronic inflammatory skin disease trajectories, spanning multiple conditions such…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Study on the Treatment of Prurigo Nodularis With Stapokibart Injection [Phase 3]
A Phase 3 trial of Stapokibart Injection for Prurigo nodularis is listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis [Phase 2, Phase 3]
A clinical trial update indicates that SHR-1819 Injection is being investigated in Phase 2 and Phase 3 studies for efficacy and safety in ad…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
A China-based clinical research project sponsored by Peking University First Hospital is currently recruiting participants for standardized …